To support COVID-19 risk mitigation, temporary changes have been made to fee item 00039 (Management of Maintenance Opioid Agonist Treatment (OAT) for Opioid Use Disorder). These changes will allow physicians to bill an appropriate visit fee in addition to fee item 00039 when visits are done for substance use risk mitigation during the pandemic. The changes are effective July 23, 2020, with the end date to be determined by the Provincial Health Officer.
00039: Management of Maintenance Opioid Agonist Treatment (OAT) for Opioid Use Disorder
Notes: Temporary changes noted in red.
- The physician does not necessarily have to have direct face-to-face contact with the patient for this fee to be paid.
- 00039 is not the only fee payable for any medically necessary service associated with maintenance opioid agonist treatment for opioid use disorder. This includes but is not limited to the following:
- At least one visit (in-person, telephone or video conference) per month with the patient after induction/stabilization on opioid agonist treatment is complete.
- At least one in-person visit with the patient every 90 days. Exception to this criterion will be considered on an individual basis.
- Supervised urine drug screening and interpretation of results.
- Simple advice/communication with other allied care providers involved in the patients OAT.
For additional details please visit the BC Family Doctors website.
For billing inquiries, please e-mail us.